Company Filing History:
6 out of 2,932 
3 out of 14 
1 out of 1 Years Active: 2009-2017
Title: **Innovations of Ka-Wang (Kevin) Wang: A Pioneer in Neural Biomarkers**
Introduction
Ka-Wang (Kevin) Wang is a notable inventor based in Gainesville, FL, whose contributions to the field of neuroscience have earned him six patents. His groundbreaking work focuses on the development of neural proteins as biomarkers for diagnosing nervous system injuries and other neural disorders, showcasing the intersection of technology and medicine.
Latest Patents
Among his latest patents, Wang has created innovative diagnostics for nerve cell injury. One notable invention identifies biomarkers that are indicative of nerve cell injury and neuronal disorders. This invention not only aids in diagnosing the presence of nerve injury but also gauges the severity and specifics of the affected cell types and subcellular locations.
Another significant patent addresses the use of synaptotagmin and collapsin response mediator proteins (CRMPs) as biomarkers for traumatic brain injury (TBI). His research indicates that CRMPs decrease in tissue but increase in biological fluids post-injury. Wang's findings demonstrate that distinct breakdown products of CRMPs can be linked to the severity of TBI, with implications for better assessment and recovery monitoring through detection in human cerebrospinal fluid.
Career Highlights
Ka-Wang (Kevin) Wang has made substantial contributions while working with the University of Florida Research Foundation and Banyan Biomarkers, Inc. His trajectory in these organizations underscores his commitment to advancing the understanding and treatment of neural injuries. His six patents reflect a dedication to enhancing diagnostic capabilities and therapeutic approaches in neuroscience.
Collaborations
Throughout his career, Wang has collaborated with esteemed colleagues, including Monika Oli and Ronald L. Hayes. These partnerships have facilitated significant advancements in research and the application of his innovations in the field.
Conclusion
Ka-Wang (Kevin) Wang's innovative patents and collaborations illustrate his valuable role in the realm of neuroscience. His focus on identifying biomarkers for nervous system injuries not only enhances diagnostic accuracy but also offers new paths for recovery and treatment of traumatic brain injuries. Wang's ongoing contributions are a testament to the importance of research and innovation in improving healthcare outcomes.